Acquisition & Growth Consulting for Healthcare Operators in Waco, TX
Waco healthcare has been quietly more interesting than its mid-sized-market profile suggests, and the operators who have built durable positions here have benefited from the relative obscurity. Out-of-region PE platforms and national consolidators have spent more time chasing Austin and DFW markets than Waco, which has kept practice valuations more reasonable and the institutional-capital pressure on margins more limited than in larger metros. That's been changing over the last 24-36 months. The Baylor Scott & White expansion in Waco, the Ascension Providence operations, the Baylor University-driven population growth, and the broader Texas demographic flow into Central Texas have all shifted what Waco's deal market looks like. The next 36-60 months are going to see real activity. Owner-operators who prepare for the shift are going to capture value. Owner-operators who don't are going to accept first inbound offers that often leave 1-2 turns of EBITDA on the table. MSG works that preparation gap.
Waco context
Waco holds approximately 145,000 residents inside the city limits with a metro population of about 295,000 across McLennan County. The city anchors a Central Texas healthcare market that pulls patient volume from across rural McLennan County, Hill County to the north, Bosque County to the west, and parts of Falls and Limestone counties to the south. Baylor University (about 20,000 students) drives a meaningful younger-demographic patient layer alongside the broader residential population.
The inpatient and ambulatory landscape includes Baylor Scott & White Medical Center Hillcrest as the dominant inpatient anchor (with Baylor Scott & White's broader Central Texas operational footprint), Ascension Providence as the major Catholic-system anchor, and DePaul Center for Behavioral Health alongside other specialty facilities. The recently-developed Baylor Scott & White Heart and Vascular Hospital in Waco anchors specialty cardiac care. Around these inpatient anchors, ambulatory specialty practices in orthopedics, cardiology, gastroenterology, dermatology, ophthalmology, ENT, urology, oncology, and primary care have real density. The Baylor University Honors College and the broader academic environment contribute to a meaningful student-and-faculty demographic that affects some specialties' patient mix.
The Waco demographic and operational reality includes substantial Hispanic and African American populations, meaningful Medicaid penetration in some submarkets alongside commercial-insurance penetration, and a regional patient-draw pattern that extends into rural Central Texas counties. The economic recovery since the late-2010s housing-and-tourism revitalization (Magnolia, Chip and Joanna Gaines effect, the broader Waco renaissance) has shifted the demographic and economic profile in specific ways that affect healthcare demand. Patient-population stability runs higher than in growth-corridor DFW or Houston suburbs, which is a defensibility story when documented. MSG is 280 miles east of Waco on I-10 and TX-6, roughly four hours by road. Engagements are structured with 3-day kickoff immersion, on-site presence at deal-cycle inflection points, and weekly video cadence between visits.
How we deliver
An MSG Waco healthcare engagement begins with the foundational disciplines applied with sensitivity to Central Texas mid-market realities. We pull three years of financial detail with normalization for owner compensation, real-estate-ownership arrangements (Waco specialty practices often own their buildings, which affects EBITDA presentation materially), and any related-party arrangements. We build payer-by-payer revenue waterfalls reflecting the local payer landscape. We map patient population by zip code with attention to the Waco metro, the rural McLennan and surrounding-county patient draw, and the university-driven patient layer.
Sell-side preparation runs through quality-of-earnings package development with attention to several Waco-specific narrative elements. The regional patient draw from rural Central Texas counties is a defensibility story that often goes underweighted when not documented. The patient-population stability — Waco residents tend to stay in Waco, and rural-county patient relationships often span decades — translates to defensibility narrative when documented. The Baylor University-driven student-and-faculty patient layer creates specialty-specific dynamics worth handling explicitly.
The buyer pool for Waco practices typically includes Baylor Scott & White acquisitions activity (which has been notably active in Central Texas over the last several years), Ascension Providence integration activity, regional and national PE platforms with Texas mid-market experience, and occasionally strategic acquirers building Central Texas regional consolidation. Process management benefits from bringing these buyer types into appropriate competitive tension. For buy-side engagements, the strategy typically focuses on tuck-in acquisitions of retiring-cohort owners or strategic specialty-line additions, with integration playbooks tuned to maintaining patient-population stability and rural-patient-draw continuity.
Healthcare specifics
Healthcare deal flow in Waco over the next 36-60 months is shaped by three structural forces. First, the Baylor Scott & White Central Texas expansion. Baylor Scott & White has been notably active in Central Texas footprint and physician-network expansion over the last several years, and Waco specifically has been a focus market. The strategic-system buyer activity from Baylor Scott & White creates real buyer interest for practices that fit, and the dynamics of negotiating with a dominant local strategic system require specific handling that MSG has experience with from comparable markets.
Second, the succession demographic. Many Waco specialty practices were established by physicians who are now in late-career territory, and the deal flow this produces over the next five years is going to be substantial relative to market size. Most of these owners haven't run competitive sale processes and are inclined to accept first inbound interest from local relationships or from Baylor Scott & White. The economic value of running a structured competitive process versus accepting first-offer dynamics is real and meaningful.
Third, the PE-platform interest in Texas mid-markets. As DFW, Austin, and metro-Houston have saturated in many specialties, Texas-specialized PE platforms have been looking at mid-sized markets like Waco, Tyler, College Station, and Lubbock with increasing interest. The buyer pool for Waco practices is broader than owner-operators sometimes assume, and the competitive tension among realistic buyers when well-managed produces meaningful valuation upside.
Why MSG
MSG works Waco engagements with operator depth and structural alignment that owner-operators tend to find more useful than what they get from local Central Texas advisory firms or distant national platforms. We're not based in Austin, Dallas, or markets with entrenched relationships to potential buyers. We charge engagement fees rather than transaction-percentage success fees. We have operator backgrounds — ServiceStorm, MFGBase, LocalAISource are production businesses we've built — that change how we evaluate deals.
We also bring willingness to invest in understanding Central Texas mid-market realities specifically. The Baylor Scott & White-dominant local dynamic, the rural patient-draw economics, the university-population operational dimensions, and the patient-population stability story all deserve specific handling. We don't pretend to be Waco specialists with decades of local market depth; we bring operator-grade discipline applied to Waco-specific realities and willingness to learn the market on our own time rather than the owner's.
And we're regional. The four-hour drive from Beaumont supports deliberate on-site presence at deal-cycle inflection points. We structure engagements around real on-the-ground time at the moments that matter rather than running everything remotely.
Outcome
Twelve months into an MSG growth or acquisition engagement, a Waco healthcare operator has navigated the deal market with deliberate strategy that captures regional patient-draw, patient-population stability, and operational quality rather than letting these value drivers go undocumented. Sell-side outcomes typically include valuations that reflect the full defensibility story, deal terms that protect the seller in earn-out and rollover structures, and post-close transitions that support owner intent. Buy-side outcomes include strategic platforms with maintained operational continuity, clean integration of acquired practices, and staff and referral-source retention through transition. Across both, the operator's strategic clarity is materially better than at engagement start.
Questions
Baylor Scott & White has approached us. They're the dominant local system. Are we obligated to take their offer seriously, or should we run a process?
Take their offer seriously, but run a process anyway if your goal is maximizing economic outcome and structural fit. Baylor Scott & White is a sophisticated and operationally capable strategic acquirer; their offers are typically real and well-structured. But sole-buyer dynamics consistently produce worse outcomes for sellers than competitive processes do — even when the eventual buyer is the original inbound. The structured process approach with Baylor Scott & White as a participating buyer (rather than the sole buyer) typically produces 1-2 turns of EBITDA improvement and meaningful deal-term improvements without damaging the buyer relationship. The work is in process discipline rather than in confrontational negotiation.
We have meaningful patient draw from rural McLennan, Hill, and Bosque counties. Is that worth documenting?
Yes, and the valuation impact is often more significant than owners realize. Rural patient draw represents predictable patient volume, lower patient-acquisition costs, multi-generation patient patterns common in stable rural communities, and reduced revenue volatility. The work in pre-sale preparation is making the regional draw legible: zip-code-level patient analysis showing the rural Central Texas reach, drive-time mapping, payer-mix analysis by geography, and a clear narrative about durability. Practices with documented rural patient relationships often retain those relationships through ownership transitions at higher rates than buyers expect, and the documentation translates to valuation premium of 0.5-1.5 turns of EBITDA over comparable practices without the documented story.
We own our practice building. Should we sell it with the practice or keep it as a separate income stream?
Depends on your post-close goals, your tax situation, and the specific buyer's preferences. The most common structure for owner-occupied medical real estate in practice sales is a long-term lease with the buyer at market-rate rent, which produces meaningful post-close income while the owner maintains the real estate as a separate asset. Some buyers prefer to acquire the real estate as part of a larger transaction, which produces a different economic and tax profile. Some structures involve sale-leasebacks to medical real estate investors with the practice tenant continuing in place. Each option has different implications for owner cash flow, tax treatment, estate planning, and post-close operational involvement. We'd structure this analysis explicitly during pre-sale preparation, working with your CPA on the tax dimensions.
What's a realistic valuation range for a Waco specialty practice in current market?
Specialty-dependent with general ranges in current market: dermatology 5-7x EBITDA, gastroenterology 6-8x, ophthalmology 6-8x, orthopedics 7-9x, ENT 5-7x, cardiology 5-7x, primary care 3-5x outside value-based-care platform pricing. Those ranges sit somewhat below DFW and Austin comparables because of demographic and market-size realities but the operational-quality spread within ranges is meaningful. Practices with documented rural patient draw, patient-population stability metrics, real-estate ownership economics, defensible referral relationships, and clean financial stories trade at the top of their range. Practices that haven't done the preparation work often trade at or below the bottom.
Most of our employees have been with us 10-20 years. How does that affect a sale?
Affects it favorably when documented and protected through the transition. Long-tenured staff represent operational continuity, clinical consistency, patient-experience quality, and reduced training and recruiting costs — all assets that buyers value. The risk is that aggressive integration disrupts those staff relationships, which can damage the operational quality buyers acquired. The work in pre-sale preparation includes documenting staff tenure and operational contributions, structuring retention provisions for key staff into the deal terms, and building integration plans that protect staff continuity. Buyers who underwrite long-tenured staff favorably also typically respect retention provisions; buyers who don't are usually wrong-fit anyway.
How does MSG handle confidentiality given Waco's smaller medical-community dynamics?
Carefully and with explicit communication planning. Waco's medical community is smaller and more reputationally tight than larger metros, and a leak about a sale process can damage the owner's standing with referring physicians, key staff, patients, and the broader community in ways that outlast the transaction. We operate with structured information control — limited information sharing during early-stage buyer engagement, structured NDA processes before sensitive operational data leaves the practice, controlled site visits, and deliberate communication plans for staff and key referral sources at appropriate stages. Owner-operators have generally walked into MSG engagements after watching one or two competitors botch confidentiality, and they care about this more than out-of-region advisors typically appreciate.
Other Industries in Waco
Growth in Other Cities
Other MSG Services
Ready to position your Waco healthcare practice for growth or exit?
Let's pull your numbers, document your regional patient-draw and operational quality, and run the process the way it should run.